مقالات
 copy 3.png){kind=small}
Naseri M, Shahsavan M, Salahshour F, Peiman S, Allameh SF, Farzanehfar S, Emami-Ardekani AR, Pouraliakbar H, Abbasi M. Effective dose for radiological procedures in an emergency department: a cross-sectional study. Radiation Protection Dosimetry. 2020 Mar;189(1):63-8.
Alibakhshi A, Farzanehfar S, Zarei M, Eftekhari M, Motiee M, Naseri M, Abbasi M. Sentinel lymph node biopsy for papillary thyroid cancer: the effect of dose, tracer and application of massage. Asia Oceania Journal of Nuclear Medicine and Biology. 2021;9(1):9.
Shiri I, Salimi Y, Pakbin M, Hajianfar G, Avval AH, Sanaat A, Mostafaei S, Akhavanallaf A, Saberi A, Mansouri Z, Askari D. COVID-19 prognostic modeling using CT radiomic features and machine learning algorithms: Analysis of a multi-institutional dataset of 14,339 patients. Computers in Biology and Medicine. 2022 Jun 1;145:105467.
Aghakhan Olia N, Kamali-Asl A, Hariri Tabrizi S, Geramifar P, Sheikhzadeh P, Farzanefar S, Arabi H, Zaidi H. Deep learning–based denoising of low-dose SPECT myocardial perfusion images: quantitative assessment and clinical performance. European journal of nuclear medicine and molecular imaging. 2022 Apr;49(5):1508-22.
Mirshahvalad SA, Chavoshi M, Hekmat S. Diagnostic performance of prone-only myocardial perfusion imaging versus coronary angiography in the detection of coronary artery disease: A systematic review and meta-analysis. Journal of Nuclear Cardiology. 2020 Oct 6:1-3.
Manafi-Farid R, Askari E, Shiri I, Pirich C, Asadi M, Khateri M, Zaidi H, Beheshti M. [18F] FDG-PET/CT radiomics and artificial intelligence in lung cancer: Technical aspects and potential clinical applications. InSeminars in Nuclear Medicine 2022 Jun 15. WB Saunders.
Schweighofer-Zwink G, Manafi-Farid R, Kölblinger P, Hehenwarter L, Harsini S, Pirich C, Beheshti M. Prognostic value of 2-[18f] FDG PET-CT in metastatic melanoma patients receiving immunotherapy. European Journal of Radiology. 2022 Jan 1;146:110107.
Saidi B, Fallahi B, Manafi-Farid R, Fard-Esfahani A, Eftekhari M. 68Ga-DOTATATE Uptake in an Intraosseous Hemangioma, as a Potential Cause of False-Positive PET/CT Finding, Simulating Tumoral Involvement. Clinical Nuclear Medicine. 2022 Jan 12.
Mohsenian Sisakht A, Karamzade-Ziarati N, Jahanbakhshi A, Shahpasand K, Aghababaei S, Ahmadvand O, Azar M, Fattahi A, Zamanzadeh S. Pathogenic cis p-tau levels in CSF reflects severity of traumatic brain injury. Neurological Research. 2022 Jan 5:1-7.
Chavoshi M, Mirshahvalad SA, Metser U, Veit-Haibach P. 68Ga-PSMA PET in prostate cancer: a systematic review and meta-analysis of the observer agreement. European Journal of Nuclear Medicine and Molecular Imaging. 2021 Nov 12:1-9.
Rezaei Aghdam H, Bitarafan Rajabi A, Sadat Ebrahimi SE, Beiki D, Abdi K, Mousavi Motlagh SS, Kiani Dehkordi B, Darbandi Azar A, Shafiee Ardestani M. 18F-FDG MicroPET and MRI Targeting Breast Cancer Mouse Model with Designed Synthesis Nanoparticles. Journal of Nanomaterials. 2022 Jun 2;2022.
Peer-Firozjaei M, Tajik-Mansoury MA, Geramifar P, Ghorbani R, Zarifi S, Miller C, Rahmim A. Optimized cocktail of 90Y/177Lu for radionuclide therapy of neuroendocrine tumors of various sizes: a simulation study. Nuclear Medicine Communications. 2022 Jun 1;43(6):646-55.
Falahatpour Z, Geramifar P, Mahdavi SR, Abdollahi H, Salimi Y, Nikoofar A, Ay MR. Potential advantages of FDG‐PET radiomic feature map for target volume delineation in lung cancer radiotherapy. Journal of applied clinical medical physics. 2022 Sep 1:e13696.
Manafi-Farid R, Ataeinia B, Ranjbar S, Araghi ZJ, Moradi MM, Pirich C, Beheshti M. ImmunoPET: Antibody-Based PET Imaging in Solid Tumors. Frontiers in medicine. 2022;9.
Eisazadeh R, Mirshahvalad SA. 18F-FDG PET/CT prognostic role in predicting response to salvage therapy in relapsed/refractory Hodgkin's lymphoma. Clinical Imaging. 2022 Dec 1;92:25-31.
Monsef A, Ay MR, Sheikhzadeh P, Geramifar P, Rahmim A, Ghafarian P. Harmonization based on quantitative analysis of standardized uptake value variations across PET/CT scanners: a multicenter phantom study. Nuclear Medicine Communications. 2022 May 18;43(9):1004-14.
Farzanefar S, Nakhjavani M, Marzban M, Eftekhari M, Albooyeh H, Naseri M, Abbasi M. Application of Neck Technetium Uptake of the Neck in Post-Operation PTC Patients for Detection of Forthcoming Iodine Ablation Response to Therapy. Indian Journal of Surgery. 2022 Jun;84(3):436-41.
Najdian A, Amanlou M, Beiki D, Bitarafan-Rajabi A, Mirzaei M, Ardestani MS. Amino-modified-silica-coated gadolinium-copper nanoclusters, conjugated to AS1411 aptamer and radiolabeled with technetium-99 m as a novel multimodal imaging agent. Bioorganic Chemistry. 2022 Aug 1;125:105827.
Saidi B, Fallahi B, Fard-Esfahani A, Emami-Ardekani A, Eftekhari M. Non-Cutaneous Melanoma, Findings and Prognostic Value of FDG PET/CT: A Case Series of 23 patients and review of the literature. Asia Oceania Journal of Nuclear Medicine and Biology. 2022;10(2):91-9.
Al-Timimi A, Manafi-Farid R, Fallahi B, Beiki D, Askari E, Rezaei A, Adinehpour Z, Eftekhari M. Factors predicting the early biochemical response to [177Lu] Lu-PSMA therapy in patients with metastatic castration resistant prostate cancer. Iranian Journal of Nuclear Medicine. 2022 Jul 1;30(2):115-21.
Mirshahvalad SA, Chavoshi M, Bahmani Kashkouli M, Fallahi B, Emami-Ardakani A, Manafi-Farid R. Diagnostic value of lacrimal scintigraphy in the evaluation of lacrimal drainage system obstruction: a systematic review and meta-analysis. Nuclear Medicine Communications. 2022 May 4;43(8):860-8.
Heidari S, Akhlaghi M, Sadeghi M, Kheirabadi AM, Beiki D, Ardekani AE, Rouhollah A, Saeidzadeh P, Soleyman R. Development of 64Cu-DOX/DOX-loaded chitosan-BSA multilayered hollow microcapsules for selective lung drug delivery. Journal of Drug Delivery Science and Technology. 2022 Jul 1;73:103477.
Haghighi F, Manafi-Farid R, Sadeghian L, Beiki D. Disseminated thoracoabdominal splenosis mimicking metastatic disease: A case of colorectal cancer. Iranian Journal of Nuclear Medicine. 2022 Jan 1;30(1):72-5.
Emami-Ardekani A, Ghorbani-Nik F, Karamzade-Ziarati N, Manafi-Farid R, Fard-Esfahani A, Fallahi B, Beiki D, Salehi Y, Eftekhari M. Impact of TSH stimulation on 2-[18F] FDG PET/CT results in patients with papillary thyroid carcinoma presented with elevated serum thyroglobulin level and negative diagnostic iodine-131 whole-body scan. Iranian Journal of Nuclear Medicine. 2022 Jul 1;30(2):88-95.
Seiedinia S, Fard-Esfahani A, Manafi-Farid R, Eftekhari M. [18F] FDG PET/CT in a case of recurrent primary cardiac osteosarcoma. Iranian Journal of Nuclear Medicine. 2022 Jan 1;30(1):62-6.
Ranjbar V, Molavipordanjani S, Biabani Ardakani J, Akhlaghi M, Nikkholgh B, Hosseinimehr SJ. Initial preclinical evaluation of 68Ga-DOTA-(Ser) 3-LTVSPWY peptide as a PET radiotracer for glioblastoma targeting and imaging. Nuclear Medicine Communications. 2022 May 4;43(8):945-51.
Shiri I, Sorouri M, Geramifar P, Nazari M, Abdollahi M, Salimi Y, Khosravi B, Askari D, Aghaghazvini L, Hajianfar G, Kasaeian A. Machine learning-based prognostic modeling using clinical data and quantitative radiomic features from chest CT images in COVID-19 patients. Computers in biology and medicine. 2021 May 1;132:104304.
Shiri I, Arabi H, Sanaat A, Jenabi E, Becker M, Zaidi H. Fully automated gross tumor volume delineation from PET in head and neck cancer using deep learning algorithms. Clinical Nuclear Medicine. 2021 Nov 1;46(11):872-83.
Manafi-Farid R, Karamzade-Ziarati N, Vali R, Mottaghy FM, Beheshti M. 2-[18F] FDG PET/CT radiomics in lung cancer: An overview of the technical aspect and its emerging role in management of the disease. Methods. 2021 Apr 1;188:84-97.
Manafi-Farid R, Harsini S, Saidi B, Ahmadzadehfar H, Herrmann K, Briganti A, Walz J, Beheshti M. Factors predicting biochemical response and survival benefits following radioligand therapy with [177Lu] Lu-PSMA in metastatic castrate-resistant prostate cancer: A review. European Journal of Nuclear Medicine and Molecular Imaging. 2021 Nov;48(12):4028-41.
Fallahi B, Khademi N, Karamzade-Ziarati N, Fard-Esfahani A, Emami-Ardekani A, Farzanefar S, Eftekhari M, Beiki D. 99mTc-PSMA SPECT/CT versus 68Ga-PSMA PET/CT in the evaluation of metastatic prostate cancer. Clinical Nuclear Medicine. 2021 Feb 1;46(2):e68-74.
Ardakani JB, Akhlaghi M, Nikkholgh B, Hosseinimehr SJ. Targeting and imaging of HER2 overexpression tumor with a new peptide-based 68Ga-PET radiotracer. Bioorganic Chemistry. 2021 Jan 1;106:104474.
Manafi-Farid R, Ranjbar S, Jamshidi Araghi Z, Pilz J, Schweighofer-Zwink G, Pirich C, Beheshti M. Molecular imaging in primary staging of prostate cancer patients: current aspects and future trends. Cancers. 2021 Oct 26;13(21):5360.
Harsini S, Fallahi B, Ziarati NK, Razi A, Amini E, Emami-Ardekani A, Fard-Esfahani A, Parizi MK, Farzanehfar S, Beiki D. A Prospective Study on [68Ga]-PSMA PET/CT Imaging in Newly Diagnosed Intermediate-and High-Risk Prostate Cancer. Asia Oceania Journal of Nuclear Medicine and Biology. 2021;9(2):101.
Almasi T, Gholipour N, Akhlaghi M, Mokhtari Kheirabadi A, Mazidi SM, Hosseini SH, Geramifar P, Beiki D, Rostampour N, Shahbazi Gahrouei D. Development of Ga-68 radiolabeled DOTA functionalized and acetylated PAMAM dendrimer-coated iron oxide nanoparticles as PET/MR dual-modal imaging agent. International Journal of Polymeric Materials and Polymeric Biomaterials. 2021 Oct 13;70(15):1077-89.
Fard-Esfahani A, Saidi B, Seyedinia S, Emami-Ardekani A, Eftekhari M. Potential role of 18F-FDG PET/CT in a case of progressive Rosai Dorfman disease. Asia Oceania Journal of Nuclear Medicine and Biology. 2021;9(1):62.
Ashoor M, Khorshidi A, Pirouzi A, Abdollahi A, Mohsenzadeh M, Barzi SM. Estimation of Reynolds number on microvasculature capillary bed using diffusion and perfusion MRI: the theoretical and experimental investigations. The European Physical Journal Plus. 2021 Feb;136(2):1-2.
Zohreh N, Rastegaran Z, Hosseini SH, Akhlaghi M, Istrate C, Busuioc C. pH-triggered intracellular release of doxorubicin by a poly (glycidyl methacrylate)-based double-shell magnetic nanocarrier. Materials Science and Engineering: C. 2021 Jan 1;118:111498.
Vosoughi H, Hajizadeh M, Emami F, Momennezhad M, Geramifar P. PET NEMA IQ Phantom dataset: image reconstruction settings for quantitative PET imaging. Data in Brief. 2021 Aug 1;37:107231.
Barati S, Enferadi M, Sarkar S, Geramifar P. The effect of magnetic field strength on the positron range and projected annihilation artifact in integrated PET/MR systems: A GATE Monte Carlo study. Medical Physics. 2021 Dec;48(12):7712-24.
Peer-Firozjaei M, Tajik-Mansoury MA, Geramifar P, Parach AA, Zarifi S. Implementation of dose point kernel (DPK) for dose optimization of 177Lu/90Y cocktail radionuclides in internal dosimetry. Applied Radiation and Isotopes. 2021 Jul 1;173:109673.
Moasses-Ghafari B, Fallahi B, Esfehani AF, Eftekhari M, Rahmani K, Eftekhari A, Geramifar P. Effect of diet on physiologic bowel 18F-FDG uptake. Journal of Nuclear Medicine Technology. 2021 Sep 1;49(3):241-5.
Olia NA, Kamali-Asl A, Tabrizi SH, Geramifar P, Sheikhzadeh P, Arabi H, Zaidi H. Investigation of Noise Reduction in Low-dose SPECT Myocardial Perfusion Images with a Generative Adversarial Network. In2021 IEEE Nuclear Science Symposium and Medical Imaging Conference (NSS/MIC) 2021 Oct 16 (pp. 1-3). IEEE.
Olia NA, Kamali-Asl A, Tabrizi SH, Geramifar P, Sheikhzadeh P, Arabi H, Zaidi H. Deep Learning-based Low-dose Cardiac Gated SPECT: Implementation in Projection Space vs. Image Space. In2021 IEEE Nuclear Science Symposium and Medical Imaging Conference (NSS/MIC) 2021 Oct 16 (pp. 1-3). IEEE.
Hajianfar G, Avval AH, Sabouri M, Khateri M, Jenabi E, Geramifar P, Oveisi M, Shiri I, Zaidi H. ComBat Harmonization of Image Reconstruction Parameters to Improve the Repeatability of Radiomics Features. In2021 IEEE Nuclear Science Symposium and Medical Imaging Conference (NSS/MIC) 2021 Oct 16 (pp. 1-3). IEEE.
Askari E, Harsini S, Vahidfar N, Divband G, Sadeghi R. 177Lu-EDTMP for Metastatic Bone Pain Palliation: A Systematic Review and Meta-Analysis. Cancer biotherapy & radiopharmaceuticals. 2021 Jun 1;36(5):383-90.
Mohtavinejad N, Hajiramezanali M, Akhlaghi M, Bitarafan-Rajabi A, Gholipour N. Synthesis and evaluation of 99mTc-DOTA-ARA-290 as potential SPECT tracer for targeting cardiac ischemic region. Iranian Journal of Basic Medical Sciences. 2021 Nov;24(11):1488.
Yavari S, Geramifar P, Fallahpoor M, Changizi V, Gholami M, Meysamie A, Farzanehfar S, Abbasi M. The effect of lithium on radioiodine thyroid tissue ablation. International Journal of Radiation Research. 2021 Oct 1;19(4):1045-8.
Fard-Esfahani A, Saidi B, Emami-Ardekani A, Fallahi B, Beiki D, Mirshahvalad SA, Eftekhari M. Adrenal lesions: Common findings and pitfalls on 18F-FDG PET/CT. Iranian Journal of Nuclear Medicine. 2021 Jul 1;29(2):97-103.
Saidi B, Fallahi B, Haghighi F, Aghaghazvini L, Mirzaian E, Eftekhari M. Three-phase 99mTc-MDP bone scan in a case of pigment villonodular synovitis. Iran J Nucl Med. 2021 Jan 1;29(1):41-4.
Saidi B, Fallahi B, Eftekhari M, Karamzade-Ziarati N, Fard-Esfahani A. Colon carcinoma metastases with extension to chest wall and pericardium. Iranian Journal of Nuclear Medicine. 2021 Jan 1;29(1):23-7.
Shiri I, Sanaat A, Jafari E, Samimi R, Khateri M, Sheikhzadeh P, Geramifar P, Dadgar H, Arabi H, Assadi M, Uribe C. Deep Active Learning Model for Adaptive PET Attenuation and Scatter Correction in Multi-Centric Studies. In2021 IEEE Nuclear Science Symposium and Medical Imaging Conference (NSS/MIC) 2021 Oct 16 (pp. 1-3). IEEE.
Saidi B, Fallahi B, Abdi A, Rakhshani N, Eftekhari M. FDG PET/CT of an Advanced Case of Malignant Nerve Sheath Tumor of Pleura. Clinical Nuclear Medicine. 2021 Jan 21.
Azar M, Mohsenian Sisakht A, Kazemi Gazik F, Shahrokhi P, Rastegar K, Karamzade-Ziarati N. PET-guided gamma knife radiosurgery in brain tumors: a brief review. Clinical and Translational Imaging. 2021 Dec;9(6):553-60.
Shiri I, Arabi H, Geramifar P, Hajianfar G, Ghafarian P, Rahmim A, Ay MR, Zaidi H. Deep-JASC: joint attenuation and scatter correction in whole-body 18F-FDG PET using a deep residual network. European journal of nuclear medicine and molecular imaging. 2020 Oct;47(11):2533-48.
Tekie FS, Hajiramezanali M, Geramifar P, Raoufi M, Dinarvand R, Soleimani M, Atyabi F. Controlling evolution of protein corona: A prosperous approach to improve chitosan-based nanoparticle biodistribution and half-life. Scientific reports. 2020 Jun 15;10(1):1-4.
Shiri I, Hajianfar G, Sohrabi A, Abdollahi H, P. Shayesteh S, Geramifar P, Zaidi H, Oveisi M, Rahmim A. Repeatability of radiomic features in magnetic resonance imaging of glioblastoma: Test–retest and image registration analyses. Medical Physics. 2020 Sep;47(9):4265-80.
Beheshti M, Manafi-Farid R, Geinitz H, Vali R, Loidl W, Mottaghy FM, Langsteger W. Multiphasic 68Ga-PSMA PET/CT in the detection of early recurrence in prostate cancer patients with a PSA level of less than 1 ng/mL: A prospective study of 135 patients. Journal of Nuclear Medicine. 2020 Oct 1;61(10):1484-90.
Gholipour N, Akhlaghi M, Kheirabadi AM, Geramifar P, Beiki D. Development of Ga-68 labeled, biotinylated thiosemicarbazone dextran-coated iron oxide nanoparticles as multimodal PET/MRI probe. International journal of biological macromolecules. 2020 Apr 1;148:932-41.
Mosayebnia M, Hajimahdi Z, Beiki D, Rezaeianpour M, Hajiramezanali M, Geramifar P, Amini M, Hatamabadi D, Shahhosseini S. Design, synthesis, radiolabeling and biological evaluation of new urea-based peptides targeting prostate specific membrane antigen. Bioorganic Chemistry. 2020 Jun 1;99:103743.
Arabi H, Shiri I, Jenabi E, Becker M, Zaidi H. Deep Learning-based Automated Delineation of Head and Neck Malignant Lesions from PET Images. In2020 IEEE Nuclear Science Symposium and Medical Imaging Conference (NSS/MIC) 2020 Oct 31 (pp. 1-3). IEEE.
Pirooznia N, Abdi K, Beiki D, Emami F, Arab SS, Sabzevari O, Pakdin-Parizi Z, Geramifar P. Radiosynthesis, Biological Evaluation, and Preclinical Study of a 68Ga-Labeled Cyclic RGD Peptide as an Early Diagnostic Agent for Overexpressed αvβ3 Integrin Receptors in Non-Small-Cell Lung Cancer. Contrast media & molecular imaging. 2020 Mar 31;2020.
Manafi-Farid R, Masoumi F, Divband G, Saidi B, Ataeinia B, Hertel F, Schweighofer-Zwink G, Morgenroth A, Beheshti M. Targeted palliative radionuclide therapy for metastatic bone pain. Journal of clinical medicine. 2020 Aug 12;9(8):2622.
Samimi R, Kamali-Asl A, Geramifar P, van den Hoff J, Rahmim A. Short-duration dynamic FDG PET imaging: optimization and clinical application. Physica Medica. 2020 Dec 1;80:193-200.
Jokar S, Erfani M, Bavi O, Khazaei S, Sharifzadeh M, Hajiramezanali M, Beiki D, Shamloo A. Design of peptide-based inhibitor agent against amyloid-β aggregation: Molecular docking, synthesis and in vitro evaluation. Bioorganic Chemistry. 2020 Sep 1;102:104050.
Behnammanesh H, Jokar S, Erfani M, Geramifar P, Sabzevari O, Amini M, Mazidi SM, Hajiramezanali M, Beiki D. Design, preparation and biological evaluation of a 177Lu-labeled somatostatin receptor antagonist for targeted therapy of neuroendocrine tumors. Bioorganic Chemistry. 2020 Jan 1;94:103381.
Shahrokhi P, Emami-Ardekani A, Harsini S, Eftekhari M, Fard-Esfahani A, Fallahi B, Ziarati NK, Akhlaghi M, Farzanefar S, Taheri AP, Beiki D. 68Ga-DOTATATE PET/CT compared with 131I-MIBG SPECT/CT in the evaluation of neural crest tumors. Asia Oceania Journal of Nuclear Medicine and Biology. 2020;8(1):8.
Paymani Z, Rohringer T, Vali R, Loidl W, Alemohammad N, Geinitz H, Langsteger W, Beheshti M. Diagnostic Performance of [18F] Fluorocholine and [68Ga] Ga-PSMA PET/CT in Prostate Cancer: A Comparative Study. Journal of clinical medicine. 2020 Jul 21;9(7):2308.
Haddad T, Fard-Esfahani A, Vali R. A review of pediatric neuroendocrine tumors, their detection, and treatment by radioisotopes. Nuclear Medicine Communications. 2020 Oct 9;42(1):21-31.
Jokar S, Behnammanesh H, Erfani M, Sharifzadeh M, Gholami M, Sabzevari O, Amini M, Geramifar P, Hajiramezanali M, Beiki D. Synthesis, biological evaluation and preclinical study of a novel 99mTc-peptide: A targeting probe of amyloid-β plaques as a possible diagnostic agent for Alzheimer’s disease. Bioorganic Chemistry. 2020 Jun 1;99:103857.
Pirooznia N, Abdi K, Beiki D, Emami F, Arab SS, Sabzevari O, Soltani-Gooshkhaneh S. 177Lu-labeled cyclic RGD peptide as an imaging and targeted radionuclide therapeutic agent in non-small cell lung cancer: Biological evaluation and preclinical study. Bioorganic Chemistry. 2020 Sep 1;102:104100.
Ehyaeeghodraty V, Molavi B, Nikbakht M, Mohammadi AM, Mohammadi S, Ehyaeeghodraty N, Fallahi B, Mousavi SA, Vaezi M, Sefidbakht S. Effects of mobilized peripheral blood stem cells on treatment of primary lower extremity lymphedema. Journal of Vascular Surgery: Venous and Lymphatic Disorders. 2020 May 1;8(3):445-51.
Harsini S, Rezaei N. Cancer imaging with radiolabeled monoclonal antibodies. InCancer Immunology 2020 (pp. 739-760). Springer, Cham.
Manafi-Farid R, Kupferthaler A, Wundsam H, Gruber G, Vali R, Venhoda C, Track C, Beheshti A, Langsteger W, Geinitz H, Beheshti M. Additional value of 2-[18F] FDG PET/CT comparing to MRI in treatment approach of anal cancer patients. Journal of clinical medicine. 2020 Aug 22;9(9):2715.
Behnammanesh H, Erfani M, Hajiramezanali M, Jokar S, Geramifar P, Sabzevari O, Amini M, Mazidi SM, Beiki D. Preclinical study of a new 177Lu-labeled somatostatin receptor antagonist in HT-29 human colorectal cancer cells. Asia Oceania Journal of Nuclear Medicine and Biology. 2020;8(2):109.
Hariri Tabrizi S, Ramezani M, Feghhi SA, Geramifar P. In vitro evaluation of an iodine radionuclide dosimeter (IRD) for continuous patient monitoring. Medical & Biological Engineering & Computing. 2020 Apr;58(4):763-9.
Emami A, Ghafarian P, Ghadiri H, Geramifar P, Ay MR. Validation and evaluation of a GATE model for MAMMI PET scanner. Iranian Journal of Nuclear Medicine. 2020 Jan 1;28(1):33-8.
Tadesse GF, Geramifar P, Ghafarian P, Cheka EE, Tegaw EM, Feyisa SG, Sadeghi R, Ay MR. Molecular imaging approaches in the diagnosis of breast cancer: A systematic review and meta-analysis. Iranian Journal of Nuclear Medicine. 2020 Jan 1;28(1):1-3.
Emami A, Ghadiri H, Ghafarian P, Geramifar P, Ay MR. Performance evaluation of developed dedicated breast PET scanner and improvement of the spatial resolution by wobbling: a Monte Carlo study. Japanese Journal of Radiology. 2020 Aug;38(8):790-9.
Fard-Esfahani A, Valipouri MR, Harsini S, Beiki D, Emami-Ardekani A, Fallahi B, Eftekhari M. Predictors of success of the ablative/therapeutic radioiodine (131I) in differentiated thyroid cancer. Iranian Journal of Nuclear Medicine. 2020 Jan 1;28(1):14-20.
Emami-Ardekani A, Harsini S, Fard-Esfahani A, Eftekhari M. Multiple myeloma in a patient with suspected hyperparathyroidism. Iranian Journal of Nuclear Medicine. 2020 Apr 1;28(1):43.
Saidi B, Fallahi B, Eftekhari M, Ghorbani M, Fard-Esfahani A. The role of FDG PET/CT in the evaluation of treatment response in a case of calcified ovarian metastases. Asia Oceania Journal of Nuclear Medicine and Biology. 2020;8(2):145.